These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2435043)

  • 1. Acute urinary retention secondary to benign prostatic hyperplasia. Effect of alpha-adrenergic blockade.
    Goodwin MI; Chester JF; Jenkins JD
    Urol Int; 1986; 41(6):430-1. PubMed ID: 2435043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia.
    Chen KK; Chang LS; Chen MT; Huang JK; Yin JH; Lin SN; Lin AD
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Feb; 41(2):127-30. PubMed ID: 2458811
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of alpha-adrenergic blockers in benign prostatic obstruction.
    Caine M; Pfau A; Perlberg S
    Br J Urol; 1976 Aug; 48(4):255-63. PubMed ID: 61054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenoxybenzamine in prostatic pathology. 300 cases (author's transl)].
    Lardennois B; El Khansa A; Amory JP; Coulon JM; Lemaire P
    J Urol (Paris); 1981; 87(4):243-8. PubMed ID: 6167646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of pharmacologic treatment in benign prostatic hyperplasia.
    Caine M
    Semin Urol; 1985 Nov; 3(4):311-6. PubMed ID: 2441447
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases.
    Caine M; Perlberg S; Shapiro A
    Urology; 1981 Jun; 17(6):542-6. PubMed ID: 6166111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute retention of urine due to benign prostatic obstruction treated with alpha-adrenergic blockers.
    Reuther K; Aagaard J
    Urol Int; 1984; 39(2):114-5. PubMed ID: 6202036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.
    Lucas MG; Stephenson TP; Nargund V
    BJU Int; 2005 Feb; 95(3):354-7. PubMed ID: 15679793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 13. [A double-blind trial on the effect of alpha-adrenergic blocker (bunazosin hydrochloride) in the symptomatic treatment of prostatism].
    Kumamoto Y; Yokoyama E; Tsukamoto T; Tsuchida S; Nishizawa O; Koshiba K; Ishibashi A; Ogawa A; Tomita Y; Aso Y
    Hinyokika Kiyo; 1987 Oct; 33(10):1681-702. PubMed ID: 2451409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
    Yokoyama T; Hara R; Fukumoto K; Fujii T; Jo Y; Miyaji Y; Nagai A; Sone A
    Int J Urol; 2011 Mar; 18(3):225-30. PubMed ID: 21272091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-adrenergic blockade in the diagnosis of detrusor instability secondary to infravesical obstruction.
    Reuther K; Aagaard J
    Urol Int; 1984; 39(5):312-3. PubMed ID: 6209842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a serotonin antagonist ketanserin on acute urinary retention.
    Hørby J; Gyrtrup HJ; Frimodt-Møller C; Mathiesen FR
    Scand J Urol Nephrol; 1989; 23(2):121-2. PubMed ID: 2474193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of urinary retention due to benign prostatic hyperplasia using luteinizing hormone-releasing hormone agonist.
    Schlegel PN; Brendler CB
    Urology; 1989 Aug; 34(2):69-72. PubMed ID: 2474882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. 1978.
    Caine M; Perlberg S; Meretyk S
    J Urol; 2002 Feb; 167(2 Pt 2):1101. PubMed ID: 11905881
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of an alpha-blocker, alfuzosin, on urinary disorders in men with prostatic adenoma. Intermediate results of a European multicenter study].
    Jardin A
    Ann Urol (Paris); 1988; 22(5):333-40. PubMed ID: 2462402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.
    Caine M; Perlberg S; Meretyk S
    Br J Urol; 1978 Dec; 50(7):551-4. PubMed ID: 88984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.